Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. [clinicaltrials:NCT00306696]
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. [clinicaltrials:NCT00306696]
Bio2RDF identifier
NCT00306696
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00306696
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Study examining the eff ...... ted
with rosiglitazone.
brief title [clinicaltrials_vocabulary:brief-title]
Examining the Effect of Differ ...... cs Treated With Rosiglitazone.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
A randomised, open-labe ...... kground anti-diabetic agents.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2006-03-22T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Type 2 diabetes
fluid retention
rosiglitazone
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-10-25T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00306696
official title [clinicaltrials_vocabulary:official-title]
See Detailed Description
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-03-01T00:00:00Z
identifier
clinicaltrials:NCT00306696
title
Examining the Effect of Differ ...... cs Treated With Rosiglitazone.
@en
type
label
Examining the Effect of Differ ...... . [clinicaltrials:NCT00306696]
@en